Filing Flows

Filing Flows › Intelligent Bio Solutions (INBS) › Q2 FY26

Intelligent Bio Solutions (INBS) Q2 FY26 earnings results (second quarter fiscal 2026)

10-Q filed Feb 12, 2026

Intelligent Bio Solutions (INBS) reported revenue of $897K for the second quarter fiscal 2026 (Q2 FY26), +21% from a year earlier and -19% from the quarter before. Operating margin was -293.9%, net loss $2.7M (299.6% of revenue).

Revenue$897K
Year over year+21%
Quarter over quarter-19%
Operating margin-293.9%
Net earnings−$2.7M

Intelligent Bio Solutions, Q2 FY26: revenue $897K (+21% year over year), operating margin -293.9%, net loss $2.7M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.

Q2 FY26AmountQ/QY/Y
Revenue$897K-19%+21%
Operating profit−$2.6M——
Net earnings−$2.7M——
Operating cash flow−$1.6M——

What changed

Revenue was $897K in Q2 FY26, up 21% year over year and down 19% from the previous quarter. Sales of Goods Cartidges was the largest line at 58% of revenue. Sales of Goods Cartidges added $128K year over year (up 33%), 83% of the total change.

Gross margin was 51.3%, up 21.2 points from Q2 FY25. Operating costs exceeded revenue by $2.6M, an operating margin of -293.9%. Operating expenses grew 24% against revenue growth of 21%. The fastest-growing cost line was SG&A (+29%). The quarter ended with a net loss of $2.7M, narrower than the previous quarter's $3.0M loss. Minority interests bore $9K of it: to shareholders the quarter was a loss of $2.7M.

Operating cash flow was −$1.6M. Non-cash charges added back $327K of depreciation and amortization and $62K of share-based compensation. Working capital and other items added $730K. Capital expenditures of $68K exceeded it, leaving free cash flow of −$1.6M.

Questions

What was Intelligent Bio Solutions' revenue in the second quarter fiscal 2026?

Intelligent Bio Solutions (INBS) reported revenue of $897K for the second quarter fiscal 2026 (Q2 FY26), +21% from a year earlier and -19% from the quarter before.

Was Intelligent Bio Solutions profitable in the second quarter fiscal 2026?

Operating loss was $2.6M (-293.9% of revenue) and net loss $2.7M.

Open the interactive Sankey →

Source: Intelligent Bio Solutions 10-Q on SEC EDGAR.